Skip to main content

Functionally Altered SH2 Domains for Biochemical Studies: Loss-of-Function Mutant and Domain Concatenation

  • Protocol
  • First Online:
Book cover SH2 Domains

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1555))

  • 1407 Accesses

Abstract

Recombinant modular protein domains have been a convenient proteomics tool for deciphering protein-protein interactions and elucidating the role of protein modifications in cell signaling. To obtain reliable experimental data, these protein domain probes require sufficient specificity and sensitivity. Since naturally evolved protein domains do not always have optimal biochemical characteristics for in vitro assays, functional alterations such as improved affinity are sometimes needed. In this chapter, we describe preparation of loss-of-function and concatenated (tandem) SH2 domains that should be widely applicable to both high- and low-throughput phosphoproteomics studies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Jadwin JA, Ogiue-Ikeda M, Machida K (2012) The application of modular protein domains in proteomics. FEBS Lett 586(17):2586–2596. doi:10.1016/j.febslet.2012.04.019

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Mayer BJ (2015) The discovery of modular binding domains: building blocks of cell signalling. Nat Rev Mol Cell Biol 16(11):691–698. doi:10.1038/nrm4068

    Article  CAS  PubMed  Google Scholar 

  3. Jones RB, Gordus A, Krall JA, MacBeath G (2006) A quantitative protein interaction network for the ErbB receptors using protein microarrays. Nature 439(7073):168–174. doi:10.1038/nature04177

    Article  CAS  PubMed  Google Scholar 

  4. Machida K, Thompson CM, Dierck K, Jablonowski K, Karkkainen S, Liu B, Zhang H, Nash PD, Newman DK, Nollau P, Pawson T, Renkema GH, Saksela K, Schiller MR, Shin DG, Mayer BJ (2007) High-throughput phosphotyrosine profiling using SH2 domains. Mol Cell 26(6):899–915. doi:10.1016/j.molcel.2007.05.031

    Article  CAS  PubMed  Google Scholar 

  5. Chen X, Tan PH, Zhang Y, Pei D (2009) On-bead screening of combinatorial libraries: reduction of nonspecific binding by decreasing surface ligand density. J Comb Chem 11(4):604–611. doi:10.1021/cc9000168

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Hause RJ Jr, Leung KK, Barkinge JL, Ciaccio MF, Chuu CP, Jones RB (2012) Comprehensive binary interaction mapping of SH2 domains via fluorescence polarization reveals novel functional diversification of ErbB receptors. PLoS One 7(9), e44471. doi:10.1371/journal.pone.0044471

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Liu BA, Engelmann BW, Jablonowski K, Higginbotham K, Stergachis AB, Nash PD (2012) SRC homology 2 domain binding sites in insulin, IGF-1 and FGF receptor mediated signaling networks reveal an extensive potential interactome. Cell Commun Signal 10(1):27. doi:10.1186/1478-811x-10-27

    Article  PubMed  PubMed Central  Google Scholar 

  8. Takakuma K, Ogo N, Uehara Y, Takahashi S, Miyoshi N, Asai A (2013) Novel multiplexed assay for identifying SH2 domain antagonists of STAT family proteins. PLoS One 8(8), e71646. doi:10.1371/journal.pone.0071646

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Liu H, Li L, Voss C, Wang F, Liu J, Li SS (2015) A comprehensive immunoreceptor phosphotyrosine-based signaling network revealed by reciprocal protein-peptide array screening. Mol Cell Proteomics 14(7):1846–1858. doi:10.1074/mcp.M115.047951

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Dierck K, Machida K, Voigt A, Thimm J, Horstmann M, Fiedler W, Mayer BJ, Nollau P (2006) Quantitative multiplexed profiling of cellular signaling networks using phosphotyrosine-specific DNA-tagged SH2 domains. Nat Methods 3(9):737–744. doi:10.1038/nmeth917

    Article  CAS  PubMed  Google Scholar 

  11. Machida K, Khenkhar M, Nollau P (2012) Deciphering phosphotyrosine-dependent signaling networks in cancer by SH2 profiling. Genes Cancer 3(5-6):353–361. doi:10.1177/1947601912459048

    Article  PubMed  PubMed Central  Google Scholar 

  12. Saito Y, Furukawa T, Arano Y, Fujibayashi Y, Saga T (2010) Fusion protein based on Grb2-SH2 domain for cancer therapy. Biochem Biophys Res Commun 399(2):262–267. doi:10.1016/j.bbrc.2010.07.066

    Article  CAS  PubMed  Google Scholar 

  13. Mayer BJ, Jackson PK, Van Etten RA, Baltimore D (1992) Point mutations in the abl SH2 domain coordinately impair phosphotyrosine binding in vitro and transforming activity in vivo. Mol Cell Biol 12(2):609–618

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Kuriyan J, Cowburn D (1997) Modular peptide recognition domains in eukaryotic signaling. Annu Rev Biophys Biomol Struct 26:259–288. doi:10.1146/annurev.biophys.26.1.259

    Article  CAS  PubMed  Google Scholar 

  15. Campbell SJ, Jackson RM (2003) Diversity in the SH2 domain family phosphotyrosyl peptide binding site. Protein Eng 16(3):217–227

    Article  CAS  PubMed  Google Scholar 

  16. Lappalainen I, Thusberg J, Shen B, Vihinen M (2008) Genome wide analysis of pathogenic SH2 domain mutations. Proteins 72(2):779–792. doi:10.1002/prot.21970

    Article  CAS  PubMed  Google Scholar 

  17. Filippakopoulos P, Muller S, Knapp S (2009) SH2 domains: modulators of nonreceptor tyrosine kinase activity. Curr Opin Struct Biol 19(6):643–649. doi:10.1016/j.sbi.2009.10.001

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Gan W, Roux B (2009) Binding specificity of SH2 domains: insight from free energy simulations. Proteins 74(4):996–1007. doi:10.1002/prot.22209

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Zheng L, Baumann U, Reymond JL (2004) An efficient one-step site-directed and site-saturation mutagenesis protocol. Nucleic Acids Res 32(14), e115. doi:10.1093/nar/gnh110

    Article  PubMed  PubMed Central  Google Scholar 

  20. Liu BA, Jablonowski K, Raina M, Arce M, Pawson T, Nash PD (2006) The human and mouse complement of SH2 domain proteins-establishing the boundaries of phosphotyrosine signaling. Mol Cell 22(6):851–868. doi:10.1016/j.molcel.2006.06.001

    Article  PubMed  Google Scholar 

  21. Ko JK, Ma J (2005) A rapid and efficient PCR-based mutagenesis method applicable to cell physiology study. Am J Physiol Cell Physiol 288(6):C1273–C1278. doi:10.1152/ajpcell.00517.2004

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Joshua Jadwin and Silas Khong Ng for assistance with editing the chapter, and Bruce Mayer for his continuous encouragement and support. This study was partly supported by grant CA1154966 from the National Institutes of Health and Quest for CURES (QFC) grant from the Leukemia and Lymphoma Society (to K.M.).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kazuya Machida .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Science+Business Media LLC

About this protocol

Cite this protocol

Ogiue-Ikeda, M., Machida, K. (2017). Functionally Altered SH2 Domains for Biochemical Studies: Loss-of-Function Mutant and Domain Concatenation. In: Machida, K., Liu, B. (eds) SH2 Domains. Methods in Molecular Biology, vol 1555. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6762-9_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-6762-9_12

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-6760-5

  • Online ISBN: 978-1-4939-6762-9

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics